Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy

Abstract Simple Summary: Enhanced glycolysis is a major feature of cancer glycometabolism, and SLC2A1 is one of the pivotal genes…